Indaptus Therapeutics Ownership | Who Owns Indaptus Therapeutics?

Indaptus Therapeutics Ownership Summary

Indaptus Therapeutics is owned by 4.56% institutional investors, 36.87% insiders, and 58.57% retail investors. Pine valley investments ltd liability is the largest institutional shareholder, holding 0.46% of INDP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.43% of its assets in Indaptus Therapeutics shares.

INDP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Indaptus Therapeutics	4.56%	36.87%	58.57%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Pine valley investments ltd liability	43.92K	0.46%	$36.99K
Citadel advisors	22.21K	0.26%	$47.09K
Susquehanna group, llp	17.83K	0.19%	$15.01K
Morgan stanley	884.00	0.01%	$1.87K
Beaird harris wealth management	300.00	0.00%	$636.00
Bank of america corp /de/	42.00	0.00%	$89.00
Two sigma securities	-	-	-
Renaissance	-	-	-
Bangor savings bank	-	-	-
Massmutual trust co fsb/adv	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pine valley investments ltd liability	43.92K	0.00%	$36.99K
Beaird harris wealth management	300.00	0.00%	$636.00
Renaissance	-	-	-
Bangor savings bank	-	-	-
Two sigma securities	-	-	-
Susquehanna group, llp	17.83K	-	$15.01K
Bank of america corp /de/	42.00	-	$89.00
Massmutual trust co fsb/adv	-	-	-
Tower research capital llc (trc)	-	-	-
Investment house	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Citadel advisors	22.21K	-	22.21K
Susquehanna group, llp	17.83K	-	17.83K
Beaird harris wealth management	300.00	0.00%	300.00
Bank of america corp /de/	42.00	-	42.00
Morgan stanley	884.00	-	-

Top Sellers

Holder	Shares	% Assets	Change
Vanguard group	-	-	-256.26K
Investment house	-	-	-128.85K
Geode capital management	-	-	-124.97K
Strategy asset managers	-	-	-45.34K
Renaissance	-	-	-28.50K

New Positions

Holder	Shares	% Assets	Change	Value
Susquehanna group, llp	17.83K	-	17.83K	$15.01K
Beaird harris wealth management	300.00	0.00%	300.00	$636.00

Sold Out

Holder	Change
Qube research	-1.00
Group one trading	-7.00
Massmutual trust co fsb/adv	-14.00
Jpmorgan chase	-17.00
Wells fargo & company/mn	-64.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	17	-10.53%	643,264	0.76%	4	10.12%	6	-25.00%	4	100.00%
Dec 31, 2024	11	-35.29%	563,412	-6.88%	5	11.81%	4	-20.00%	2	-50.00%
Sep 30, 2024	17	-19.05%	605,020	0.85%	7	14.02%	5	-44.44%	4	33.33%
Jun 30, 2024	21	23.53%	599,915	2.07%	7	14.52%	9	200.00%	3	-40.00%
Mar 31, 2024	17	-5.56%	587,768	-2.40%	6	13.61%	3	-62.50%	5	150.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	229.20K	1.43%	-
Fidelity Extended Market Index	2.39K	0.42%	-
Spartan Extended Market Index Pool E	14.31K	0.10%	13.39K
Fidelity Nasdaq Composite Index	14.12K	0.10%	-
Spartan Extended Market Index Pool F	14.96K	0.09%	-
Fidelity Series Total Market Index	507.00	0.09%	-
Fidelity Total Market Index	462.00	0.08%	-
SSgA U.S. Extended Market Index Class I	6.40K	0.06%	-
Vanguard Institutional Extnd Mkt Idx Tr	664.00	0.06%	-302.00
NT Ext Equity Mkt Idx Fd - NL	214.00	0.04%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 14, 2023	Anderson Glen R.	-	Buy	$56.01K
Aug 10, 2023	Anderson Glen R.	-	Buy	$86.05K
Aug 11, 2023	Anderson Glen R.	-	Buy	$74.34K
Nov 22, 2022	Litchev Boyan Vesselinov	Chief Medical Officer	Buy	$915.00
Dec 01, 2022	Litchev Boyan Vesselinov	Chief Medical Officer	Buy	$935.45

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

INDP Ownership FAQ

Who Owns Indaptus Therapeutics?

Indaptus Therapeutics shareholders are primarily institutional investors at 4.56%, followed by 36.87% insiders and 58.57% retail investors. The average institutional ownership in Indaptus Therapeutics's industry, Biotech Stocks , is 306.59%, which Indaptus Therapeutics falls below.

Who owns the most shares of Indaptus Therapeutics?

Indaptus Therapeutics’s largest shareholders are Pine valley investments ltd liability (43.92K shares, 0.46%), Citadel advisors (22.21K shares, 0.26%), and Susquehanna group, llp (17.83K shares, 0.19%). Together, they hold 0.91% of Indaptus Therapeutics’s total shares outstanding.

Does Blackrock own Indaptus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Indaptus Therapeutics.

Who is Indaptus Therapeutics’s biggest shareholder by percentage of total assets invested?

Pine valley investments ltd liability is Indaptus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 43.92K Indaptus Therapeutics shares, valued at 36.99K$.

Who is the top mutual fund holder of Indaptus Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Indaptus Therapeutics shares, with 1.43% of its total shares outstanding invested in 229.2K Indaptus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools